Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement Regarding Share Price Movement

19 Mar 2020 07:00

RNS Number : 7092G
Arden Partners plc
19 March 2020
 

Arden Partners plc

("Arden" or the "Company")

 

Statement Regarding Share Price Movement

Arden (AIM: ARDN) has noted the recent downward movement in its share price, in particular on 18 March 2020, on very small volumes.

The Board understands the current volatile nature of the stock market and the impact of this on relatively illiquid stocks, but it wishes to advise shareholders that, as at 29 February 2020, the unaudited net asset value of the Company was £5.6m (equating to a net asset value per share of 19.2 pence).

The Company's preliminary results statement (released on 3 February 2020), highlighted that it was well capitalised as at its latest year end and the Board confirms that it remains so.

The Board's priority will be to protect the Company's balance sheet whilst remaining focussed on delivering its stated growth strategy and on servicing Arden's clients' needs. This remains the case despite the current difficult market conditions.

For further enquiries:

Arden Partners plc

020 7614 5900

Steve Douglas - Group Finance Director

 

GCA Altium Limited

 

020 7484 4040

Sam Fuller / Tim Richardson

 

Notes for editors

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

The recently added Arden Wealth Management team offers a bespoke discretionary service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
SPMEANDPFALEEFA
Date   Source Headline
9th Oct 201911:55 amRNSForm 8.5 (EPT/NON-RI)
2nd Oct 201911:55 amRNSForm 8.5 (EPT/NON-RI)
26th Sep 201911:55 amRNSForm 8.5 (EPT/NON-RI)
25th Sep 201912:10 pmRNSForm 8.5 (EPT/NON-RI)
24th Sep 201911:55 amRNSForm 8.5 (EPT/NON-RI)
23rd Sep 201912:13 pmRNSForm 8.5 (EPT/NON-RI)
20th Sep 201911:55 amRNSForm 8.5 (EPT/NON-RI)
19th Sep 201912:35 pmRNSForm 8.5 (EPT/NON-RI)
18th Sep 201911:55 amRNSForm 8.5 (EPT/NON-RI)
13th Sep 201911:55 amRNSForm 8.5 (EPT/NON-RI)
12th Sep 201911:55 amRNSForm 8.5 (EPT/NON-RI)
11th Sep 20193:49 pmRNSDirector/PDMR Shareholding
11th Sep 201911:55 amRNSForm 8.5 (EPT/NON-RI)
6th Sep 201912:07 pmRNSForm 8.5 (EPT/NON-RI)
5th Sep 201911:55 amRNSForm 8.5 (EPT/NON-RI)
4th Sep 201911:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Sep 201911:55 amRNSForm 8.5 (EPT/NON-RI)
2nd Sep 201911:54 amRNSHolding(s) in Company
30th Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
29th Aug 20193:57 pmRNSCorrection - Share Purchase by EBT and TR1
29th Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
28th Aug 20194:08 pmRNSShare Purchase by EBT
27th Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
23rd Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
23rd Aug 20198:28 amRNSHolding(s) in Company
22nd Aug 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
20th Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
19th Aug 201912:14 pmRNSForm 8.5 (EPT/NON-RI)
16th Aug 201912:11 pmRNSForm 8.5 (EPT/NON-RI)
15th Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
14th Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
13th Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
13th Aug 20198:58 amRNSDirector/PDMR Shareholding
12th Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
9th Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
5th Aug 201911:55 amRNSForm 8.5 (EPT/NON-RI)
31st Jul 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Jul 201911:55 amRNSForm 8.5 (EPT/NON-RI)
26th Jul 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 201911:55 amRNSForm 8.5 (EPT/NON-RI)
25th Jul 20197:00 amRNSInterim Results - Six Months Ended 30th April 2019
24th Jul 201911:55 amRNSForm 8.5 (EPT/NON-RI)
23rd Jul 201911:55 amRNSForm 8.5 (EPT/NON-RI)
22nd Jul 201911:57 amRNSForm 8.5 (EPT/NON-RI)
11th Jul 201911:56 amRNSDirector/PDMR Shareholding
13th Jun 201911:55 amRNSForm 8.5 (EPT/NON-RI)
11th Jun 201912:52 pmRNSDirector/PDMR Shareholding
11th Jun 201911:55 amRNSForm 8.5 (EPT/NON-RI)
5th Jun 201911:55 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.